Milnacipran Hydrochloride

CAS 101152-94-7 14 current records 2 historicalSmall Molecule

Who holds supplier records for Milnacipran Hydrochloride? 14 organisations hold a current record for Milnacipran Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (10), Italy (1), Spain (1) and France (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Milnacipran Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/milnacipran-hydrochloride

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Milnacipran Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India10Italy1Spain1France1Country not recorded for 1
Need Milnacipran Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Milnacipran Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Milnacipran Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used primarily for the treatment of major depressive disorder and fibromyalgia. It works by increasing the levels of serotonin and norepinephrine in the brain to help maintain mental balance.

Chemical identity

IUPAC name
[(1S,2R)-2-(diethylcarbamoyl)-2-phenylcyclopropyl]methylazanium chloride
Canonical SMILES
CCN(CC)C(=O)[C@@]1(C[C@@H]1C[NH3+])C2=CC=CC=C2.[Cl-]
InChIKey
XNCDYJFPRPDERF-PBCQUBLHSA-N
Synonyms
Savella API, dalcipran, ixel, milnacipran hcl, nsc-759806, savella, toledomin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action
Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors

Therapeutic areas

PsychiatryNeurologyPain Management

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Milnacipran Hydrochloride?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Milnacipran Hydrochloride: ALIVUS LIFE SCIENCES LTD (India), CENTAUR PHARMACEUTICALS PVT LTD (India), COSMA SPA (Italy), DERIVADOS QUIMICOS SAU (Spain), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), LUPIN MANUFACTURING SOLUTIONS LTD and Macleods Pharmaceuticals Ltd. (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Milnacipran Hydrochloride Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 25022), CENTAUR PHARMACEUTICALS PVT LTD (DMF 26577), COSMA SPA (DMF 25717), DERIVADOS QUIMICOS SAU (DMF 26611), Dr. Reddy's Laboratories Ltd. (DMF 25865), Hetero Labs Limited (DMF 26515), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 26620) and Macleods Pharmaceuticals Ltd. (DMF 30983) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Milnacipran Hydrochloride records mean?

2 organisations have only inactive Type II DMFs for Milnacipran Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Milnacipran Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Milnacipran Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.